Clinical Trial Update: Prediction of Cognitive Properties of New Drug Candidates for Neurodegenerative Diseases in Early Clinical Development [Phase 1]

View source ↗

Summary

An early-phase clinical trial evaluating cognitive properties of new drug candidates for Alzheimer's disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: University Hospital, Lille | Conditions: Alzheimer Disease, Battery | Phase 1 | Status: COMPLETED